Categories: Business

Google Creative Labs launches Alto machine learning gadget

Google Creative Lab (Google Creative Lab) this week introduced a new project called Alto, aimed at teaching through the Coral USB Accelerator. For users who want to master the basics of machine learning, Alto can provide a learning method suitable for various hardware projects, and the code and templates of the project are free.

It is reported that the full name of ALTO is “A Little Teachable Object” (a small teachable object). As an open source AI experimental project, its various components are easily available.

After completing the hardware assembly and software adaptation, users need to use a single button, robotic arm and camera to help Alto learn two types of work.

One of the tasks is to raise one arm when a certain object is recognized, and then raise the other arm when another object is recognized.

Jimmy Fraley

Recent Posts

GRUPO ELEKTRA ANNOUNCES REVENUE OF Ps.40,045 MILLION AND EBITDA OF Ps.4,119 MILLION IN THE THIRD QUARTER OF 2022

Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services…

2 years ago

mCloud Announces Proposed Unsecured Loan from Strategic Investors

mCloud Technologies Corp. (Nasdaq: MCLD) (TSX-V: MCLD), ("mCloud" or the "Company") a leading provider of AI-powered asset…

2 years ago

TransPerfect Acquires Sterling Technology

TransPerfect, the world's largest provider of language and technology solutions for global business, announced that…

2 years ago

Comerica Incorporated Names Kelly Gage, Director of Investor Relations; Darlene Persons to Retire on April 1

Comerica Incorporated (NYSE: CMA) announced that Kelly Gage, National Director of Sales and Strategy for the Commercial Bank…

2 years ago

Genomadix Inc. Announces Know-How License Agreement with Mayo Clinic

Genomadix announced it has entered into a know-how license agreement and stock purchase agreement with…

2 years ago

ASLAN Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the…

2 years ago

This website uses cookies.